Cargando…
TCR-T Immunotherapy: The Challenges and Solutions
T cell receptor-engineered T cell (TCR-T) therapy is free from the limit of surface antigen expression of the target cells, which is a potential cellular immunotherapy for cancer treatment. Significant advances in the treatment of hematologic malignancies with cellular immunotherapy have aroused the...
Autores principales: | Liu, Yating, Yan, Xin, Zhang, Fan, Zhang, Xiaoxia, Tang, Futian, Han, Zhijian, Li, Yumin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822241/ https://www.ncbi.nlm.nih.gov/pubmed/35145905 http://dx.doi.org/10.3389/fonc.2021.794183 |
Ejemplares similares
-
Application of Immunotherapy in Hepatocellular Carcinoma
por: Miao, Lele, et al.
Publicado: (2021) -
Obstacles and Coping Strategies of CAR-T Cell Immunotherapy in Solid Tumors
por: Miao, Lele, et al.
Publicado: (2021) -
Clinical Features and Prognostic Factors of Acute Ischemic Stroke Related to Malignant Gastrointestinal Tumor
por: Liu, Yating, et al.
Publicado: (2021) -
Construction of targeted (10)B delivery agents and their uptake in gastric and pancreatic cancer cells
por: Wang, Song, et al.
Publicado: (2023) -
Antigen-Specific TCR-T Cells for Acute Myeloid Leukemia: State of the Art and Challenges
por: Kang, Synat, et al.
Publicado: (2022)